SNOA
Sonoma Pharmaceuticals Inc
NASDAQ: SNOA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.10
+3.77% today
Updated 2026-04-30
Market cap
$4.98M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-1.95
Dividend yield
—
52W range
$1 – $7
Volume
0.2M
Sonoma Pharmaceuticals Inc (SNOA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-19.00%
Operating margin
-15.60%
ROE
-81.20%
ROA
-12.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.58M | $-23.10M | -89.71% | -806.93% | -893.92% |
| 2007 | $4.54M | $-19.78M | 33.99% | -428.88% | -435.46% |
| 2008 | $3.83M | $-20.34M | 28.27% | -584.75% | -530.35% |
| 2009 | $5.39M | $-17.66M | 52.00% | -321.21% | -327.69% |
| 2010 | $7.36M | $-8.23M | 52.66% | -108.85% | -111.79% |
| 2011 | $9.75M | $-7.95M | 62.96% | -76.94% | -81.48% |
| 2012 | $12.74M | $-7.33M | 68.38% | -50.75% | -57.51% |
| 2013 | $15.45M | $-5.43M | 69.52% | -21.84% | -35.15% |
| 2014 | $13.67M | $3.73M | 61.44% | -44.27% | 27.33% |
| 2015 | $13.85M | $-8.20M | 52.61% | -48.07% | -59.21% |
| 2016 | $9.37M | $-10.16M | 28.26% | -157.05% | -108.46% |
| 2017 | $12.82M | $9.27M | 44.19% | -101.16% | 72.31% |
| 2018 | $16.66M | $-14.33M | 43.88% | -85.18% | -86.01% |
| 2019 | $18.97M | $-11.80M | 46.81% | -59.35% | -62.19% |
| 2020 | $17.93M | $-3.31M | 45.30% | -41.22% | -18.45% |
| 2021 | $18.63M | $-3.95M | 35.21% | -18.51% | -21.20% |
| 2022 | $12.63M | $-5.09M | 31.62% | -46.62% | -40.28% |
| 2023 | $13.27M | $-5.15M | 33.73% | -34.43% | -38.81% |
| 2024 | $12.73M | $-4.83M | 37.26% | -36.91% | -37.97% |
| 2025 | $14.29M | $-3.46M | 38.25% | -25.97% | -24.20% |